References
- Dresse M-F, David M, Hame H. Successful treatment of Kasabach-Merritt syndrome with prednisone and epsilon-amino caproic acid. Pediatr Hematol Oncol. 1991; 8: 329–334
- Özsoylu S, Irken G, Gürgey A. High dose intravenous methylprednisolone for Kasabach-Merritt syndrome. Eur J Pediatr. 1989; 148: 403–405
- Özsoylu Ş. High dose of methylprednisolone for Kasabach-Merritt syndrome. J Pediatr. 1991; 119: 676
- Özsoylu Ş, Ertürk G. Oral megadose methylprednisolone for childhood acute idiopathic thrombocytopenic purpura (ITP). Blood 1991; 77: 1856–1857
- Özsoylu Ş. High-dose intravenous methylprednisolone (HIVMP) in hematologic disorders. Hematol Rev. 1990; 4: 197–207
- Ozsoylu Ş. High-dose intravenous corticosteroid treatment for patients with Diamond-Blackfan syndrome resistant or refractory to conventional treatment. J Pediatr Hematol Oncol. 1988; 10: 217–223
- Warrell RP, Jr, Kempin S J. Treatment of severe coagulopathy in the Kasabach-Merritt syndrome with aminocaproic acid and cryoprecipitate. N Engl J Med. 1985; 313: 309–312
- Ortel T L, Onorato J J, Bedrosian C L, Kaufman R E. Antifibrinolytic therapy in the management of the Kasabach-Merritt syndrome. Am J Hematol. 1988; 24: 44–48